Mohamed Hassan Bakri

Mohamed Hassan Bakri

Auto-generated profile, based on publicly available information

Mohamed Hassan Bakri

Department of Anesthesia, Faculty of Medicine, Assiut University, Assiut, Egypt

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2006 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
PDF file
JBJanet M. Boyle
Janet M. Boyle
SMSoundous Moualla
Soundous Moualla
SASusana Arrigain
Susana Arrigain
SWSarah Worley
Sarah Worley
MBMohamed H. Bakri
Mohamed H. Bakri
CTCharuhas V. Thakar
Charuhas V. Thakar

1 February 2007 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
JYJean-Pierre Yared
Jean-Pierre Yared
MBMohamed H. Bakri
Mohamed H. Bakri
SESerpil C. Erzurum
Serpil C. Erzurum
CMChristine S. Moravec
Christine S. Moravec
DLDaniel M. Laskowski
Daniel M. Laskowski
JTJulie Thornton
Julie Thornton

1 April 2015 in Saudi Journal of Anaesthesia
Verified
Journal Article
Open access
PDF file
MBMohamed H. Bakri
Mohamed H. Bakri
EIEman A. Ismail
Eman A. Ismail
MAMohamed S. Ali
Mohamed S. Ali
GEGhada O. Elsedfy
Ghada O. Elsedfy
TSTaher A. Sayed
Taher A. Sayed
AIAhmed Ibrahim
Ahmed Ibrahim
Background: Preclinical and clinical data suggest the possibility of neurotoxicity following exposure of young children to general anesthetics with subsequent behavioral disturbances. The aim of the study was to determine the overall effect of repeated general anesthesia on behavior and emotions of young children aged 1½-5 years old, compared to healthy children. Materials and Methods: Thirty-five children underwent repeated anesthesia and surgery were matched with the same number of healthy children who attended vaccination clinic, as a control group. Both groups were administered the child behavior checklist (CBCL) 1½-5 years and Diagnostic and Statistical Manual of Mental Disorders (DSM) oriented scale. Behavior data were collected through a semi-structured questionnaire. Results: The CBCL score revealed that children with repeated anesthesia were at risk to become anxious or depressed (relative risk [RR]; 95% confidence interval [CI] = 11 [1.5-80.7]), to have sleep (RR; 95% CI = 4.5 [1.1-19.4]), and attention problems (RR; 95% CI = 8 [1.1-60.6]). There was no difference in the risk between the two groups regarding emotionally reactive, somatic complaints, withdrawn problems, aggressive behavior, internalizing or externalizing problems. On DSM scale, children with repeated anesthesia were at risk to develop anxiety problems (RR; 95% CI = 3.7 [1.1-12.0]), and attention deficit/hyperactivity problems (RR; 95% CI = 3 [1.1-8.4]). There was no difference in the risk between the two groups regarding affective, pervasive developmental and oppositional defiant problems. Conclusion: Young children who undergone repeated surgical procedures under general anesthesia were at risk for subsequent behavioral and emotional disturbances. Proper perioperative pain management, social support, and avoidance of unpleasant surgical experiences could minimize these untoward consequences.

1 January 2015 in Korean Journal of Anesthesiology
Verified
Journal Article
Open access
PDF file
MBMohamed H. Bakri
Mohamed H. Bakri
EIEman A. Ismail
Eman A. Ismail
AIAhmed Ibrahim
Ahmed Ibrahim
Bakri MH, et al. Korean J Anesthesiol. 2015 Jun;68(3):254-260. http://dx.doi.org/10.4097/kjae.2015.68.3.254

1 March 2008 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
SISteven R. Insler
Steven R. Insler
MBMohamed H. Bakri
Mohamed H. Bakri
FNFady Nageeb
Fady Nageeb
EMEdward Mascha
Edward Mascha
TMTomislav Mihaljevic
Tomislav Mihaljevic
DSDaniel I. Sessler
Daniel I. Sessler
A new underbody forced-air warming system is available for use during cardiac surgery. We tested the hypothesis combining underbody forced-air warming with standard thermal management would maintain intraoperative core temperature and reduce core temperature after-drop (largest decrease in core temperature in the 60 min after bypass) in patients undergoing near-normothermic cardiopulmonary bypass (CPB). Patients undergoing routine, nonemergent cardiac surgery were randomly assigned to routine thermal management (fluid warming and passive insulation, n = 30) or routine management supplemented by an active underbody forced-air system (n = 30; Arizant Healthcare Model 635, Eden Prairie, MN). Core body temperature was measured by bladder catheter at 15-min intervals during the perioperative period. Comparisons were made between groups for temperature before, during, and after CPB. Data from four patients were excluded for cause, leaving 29 patients in the routine management group and 27 patients in the forced-air group. Initial temperatures were similar, but temperatures in the forced-air group were higher than in the routine group at the start of CPB (36.3 degrees C +/- 0.6 degrees C vs 35.7 degrees C +/- 0.7 degrees C, P = 0.002). There were no differences between groups in the lowest temperatures during CPB (forced air, 35.5 degrees C +/- 1.5 degrees C vs routine, 35.3 degrees C +/- 1.3 degrees C, P = 0.67); the end of CPB (36.7 degrees C +/- 0.4 degrees C vs 36.6 degrees C +/- 0.4 degrees C, P > 0.99); or the temperature at departure from the operating room (36.5 degrees C +/- 0.4 degrees C vs 36.2 degrees C +/- 0.5 degrees C, P = 0.36). After-drop was 0.03 degrees C +/- 0.54 degrees C in patients randomized to underbody forced-air warming and 0.21 degrees C +/- 0.51 degrees C in those assigned to routine management (P = 0.20). Adding an underbody forced-air warming system to the near-normothermic thermal management protocol significantly increased pre-bypass temperature; however, it had no further clinically important effect on core temperature.

1 October 2008 in Journal of Neurosurgical Anesthesiology
Verified
Journal Article
Closed access
MMMarco A. Maurtua
Marco A. Maurtua
ADAnupa Deogaonkar
Anupa Deogaonkar
MBMohamed H. Bakri
Mohamed H. Bakri
EMEdward Mascha
Edward Mascha
JNJie Na
Jie Na
ASArmin Schubert
Armin Schubert
In neuroanesthesia practice, muscle relaxants may at times need to be avoided to facilitate intraoperative motor pathway monitoring. Our study's objective was to determine the optimal dose of remifentanil required to prevent movement after neurosurgical stimulation. After Institutional Review Board approval and written informed consent, 132 patients undergoing elective craniotomy randomly received one of 12 remifentanil dose regimens (0.10 to 0.21 microg/kg/min). Remifentanil was started before induction with propofol and succinylcholine. Anesthesia was maintained with isoflurane (0.6% end-tidal) in air/oxygen. During the study, movement was assessed on predetermined criteria by the anesthesiology, nursing, and neurosurgical teams. Heart rate and blood pressure were recorded every 5 minutes. We assessed the relationship between movement, hypotension, bradycardia, and dose using probit analysis and logistic regression. Sixty-five percent of the patients moved in response to surgical stimuli [95% confidence interval (CI): 49%-79%] at a remifentanil infusion rate of 0.10 microg/kg/min, and movement decreased to 21% (95% CI: 11-35) at 0.21 microg/kg/min. The probability of movement was 50% at an infusion rate (95% CI) of 0.13 (0.10 to 0.15) microg/kg/min remifentanil and decreased to 25% at an infusion rate of 0.19 (0.17 to 0.29) microg/kg/min. The probability of hypotension and bradycardia was 50% at 0.13 (0.10 to 0.15) microg/kg/min and 0.17 (0.15 to 0.21) microg/kg/min, respectively. Higher doses of remifentanil lessen the risk of movement in the absence of muscle relaxants with surgical stimulation for elective craniotomy. Hypotension and bradycardia were common at higher doses. Even at the maximum dose (0.21 mcg/kg/min) there was a 20% chance of movement. Adjunctive therapy is needed to ablate movement reliably, and to counteract the hypotensive effect of remifentanil. These findings may be helpful for clinicians administering remifentanil and isoflurane during procedures, where muscle relaxants may not be desirable.